340 related articles for article (PubMed ID: 11918236)
1. Anaplastic thyroid carcinoma in ecuador: analysis of prognostic factors.
Pacheco-Ojeda LA; Martínez AL; Alvarez M
Int Surg; 2001; 86(2):117-21. PubMed ID: 11918236
[TBL] [Abstract][Full Text] [Related]
2. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
[TBL] [Abstract][Full Text] [Related]
4. Anaplastic thyroid carcinoma: a case of a young women that reports a survival exceeding 6 years.
Batori M; Chatelou E; Straniero A; Ruggieri M
Eur Rev Med Pharmacol Sci; 2007; 11(1):69-71. PubMed ID: 17405351
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches.
Are C; Shaha AR
Ann Surg Oncol; 2006 Apr; 13(4):453-64. PubMed ID: 16474910
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach.
Veness MJ; Porter GS; Morgan GJ
ANZ J Surg; 2004 Jul; 74(7):559-62. PubMed ID: 15230790
[TBL] [Abstract][Full Text] [Related]
8. [Anaplastic carcinoma of the thyroid at the Instituto Nacional de la Nutrición Salvador Zubirán].
Sierra M; Gamboa-Domínguez A; Herrera MF; Barredo-Prieto B; Alvarado de la Barrera C; Llorente L; Pérez-Enriquez B; Rivera R; González O; Rull JA
Rev Invest Clin; 1997; 49(2):97-103. PubMed ID: 9380971
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid.
Sugitani I; Kasai N; Fujimoto Y; Yanagisawa A
World J Surg; 2001 May; 25(5):617-22. PubMed ID: 11369989
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma.
Akaishi J; Sugino K; Kitagawa W; Nagahama M; Kameyama K; Shimizu K; Ito K; Ito K
Thyroid; 2011 Nov; 21(11):1183-9. PubMed ID: 21936674
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of anaplastic thyroid carcinoma. Our experience.
Palestini N; Brignardello E; Freddi M; Piovesan A; Pipitone Federico NS; Sisto G; Robecchi A
G Chir; 2010; 31(6-7):282-5. PubMed ID: 20646371
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy.
De Crevoisier R; Baudin E; Bachelot A; Leboulleux S; Travagli JP; Caillou B; Schlumberger M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1137-43. PubMed ID: 15519785
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups.
Heron DE; Karimpour S; Grigsby PW
Am J Clin Oncol; 2002 Oct; 25(5):442-6. PubMed ID: 12393980
[TBL] [Abstract][Full Text] [Related]
14. Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients.
Swaak-Kragten AT; de Wilt JH; Schmitz PI; Bontenbal M; Levendag PC
Radiother Oncol; 2009 Jul; 92(1):100-4. PubMed ID: 19328572
[TBL] [Abstract][Full Text] [Related]
15. [The combined treatment of anaplastic thyroid carcinoma].
Serrano M; Monroy C; Rodríguez-García JL; País JR; Fernández-Garrido M
An Med Interna; 1994 Jun; 11(6):288-90. PubMed ID: 7918941
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
[TBL] [Abstract][Full Text] [Related]
17. Effect of primary treatment on survival in anaplastic thyroid carcinoma.
Besic N; Auersperg M; Us-Krasovec M; Golouh R; Frkovic-Grazio S; Vodnik A
Eur J Surg Oncol; 2001 Apr; 27(3):260-4. PubMed ID: 11373102
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of anaplastic thyroid carcinoma.
Kihara M; Miyauchi A; Yamauchi A; Yokomise H
Surg Today; 2004; 34(5):394-8. PubMed ID: 15108075
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.
Siironen P; Hagström J; Mäenpää HO; Louhimo J; Heikkilä A; Heiskanen I; Arola J; Haglund C
Oncology; 2010; 79(5-6):400-8. PubMed ID: 21455012
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]